- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03702712
Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial (RACER)
Acute Effects of Aerobic Exercise and Relaxation on Fatigue and Executive Function in Breast Cancer Survivors
Przegląd badań
Status
Warunki
Szczegółowy opis
It is hypothesized that the combination of aerobic exercise and relaxation training could have additive effects on fatigue and related cognitive outcomes. Therefore, this study is designed to test the effects of exercise plus relaxation relative to aerobic exercise alone and relaxation training alone, over the course of three sessions within a seven day period. Participants will complete baseline and post-testing before and after the week of training, as well as pre- and post-testing at each session.
Participants will be randomized to one of three conditions:
- Aerobic Exercise Only Condition (AERO) Participants randomized to the AERO condition will engage in three separate 20-minute sessions comprised of a 5-minute, resistance-free warm-up, and 15 minutes of moderate aerobic cycling on a stationary bike (50-70% age-predicted heart rate max). Each AERO session will end with a 20-minute quiet rest period.
- Relaxation Only Condition (RELAX) Participants in the RELAX condition will complete three separate 20-minute sessions of relaxation training using a commercial neurofeedback device (headset & smartphone app). Each RELAX session will end with a 20-minute quiet rest period.
- Aerobic Exercise and Relaxation Training - Intervention Condition (COMBINED) Participants randomized to the COMBINED condition will complete three separate sessions comprised of 20 minutes of AERO exercise followed by 20 minutes of RELAX training.
All participants, regardless of condition will complete brief questionnaires assessing in-the-moment fatigue and affect, before and after each randomly assigned activity session. A larger survey and battery of cognitive tests will be completed at the beginning of the first appointment and at the conclusion of the third appointment.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Illinois
-
Urbana, Illinois, Stany Zjednoczone, 61801
- University of Illinois at Urbana-Champaign
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- 18 years and older
- previously diagnosed with breast cancer (ductal carcinoma in situ or stages I-IV)
- completed at least one cycle of chemotherapy treatment within the last 5 years
- must have reliable access to the internet
- must report at least one complaint concerning physical function, fatigue, memory, planning, thinking, negative mood, depressive symptoms, or anxiety
- must be capable of engaging in sustained stationary cycling at a moderate intensity
Exclusion Criteria:
- deaf in both ears
- unable to comfortably wear a pair of ear-bud headphones
- color-blind or do not have vision of at least 20/40 with the aid of contacts or glasses
- history or diagnosis of epilepsy
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Potroić
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Aktywny komparator: Aerobic Exercise Only
Participants in the Aerobic Exercise Only arm will engage in three separate 20-minute sessions comprised of a 5-minute, resistance-free warm-up, and 15 minutes of moderate stationary aerobic cycling on a Cybex bike #525C (50-70% age-predicted heart rate max).
Each session will be followed by 20 minutes of uninterrupted quiet rest.
The bike will provide feedback including speed, rotations per minute, and time.
|
This intervention will combine 20 minutes of moderate aerobic exercise followed by 20 minutes of quiet rest.
|
|
Aktywny komparator: Relaxation Only
Participants in the Relaxation Only arm will complete three separate 20-minute sessions of relaxation using a commercial wearable neurofeedback (headband) device.
The device's accompanying software (connected to the headband through Bluetooth) encourages breathing strategies in response to recorded brain wave activity.
Real time auditory feedback includes sounds of calm (soft) or loud winds in response to detected brain activity.
A visual report of affective states and the user's brain activity is given (alpha and beta waves).
Participants will also be asked to take part in 20 minutes of uninterrupted quiet rest in order to match the time of the aerobic only condition.
|
This intervention will combine 20 minutes of mindfulness-based relaxation training followed by 20 minutes of quiet rest.
|
|
Eksperymentalny: Aerobic Exercise and Relaxation
Participants in the Aerobic Exercise and Relaxation arm will complete the three separate 20-minute aerobic exercise sessions (identical to the aerobic exercise only condition) followed by the same 20-minute neurofeedback-guided mindfulness training (identical to the relaxation only condition).
|
This intervention will combine 20 minutes of moderate aerobic exercise followed by 20 minutes of mindfulness training.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Piper Fatigue Scale
Ramy czasowe: This will be assessed on day 1 (baseline), day 2 and day 3 (post-testing), both before and after randomized activities.
|
The Piper Fatigue Scale requires respondents to select their answers according to a "0" (most positive or desirable response) to "10" (most negative, fatigue is having a strong impact) scale.
A total fatigue score is calculated by summing each of the 12 responses and dividing by 12. Accordingly, a total fatigue change score of 0 corresponds to no fatigue, a score of 1-3 is labeled as mild, 4-6 is labeled as moderate, and 7-10 is labeled as severe.
The total scores from each of the three days will be used to calculate an overall fatigue score, which will be used to assess group level differences across averages.
Our operational definition of overall fatigue in this outcome is the average score across each group.
|
This will be assessed on day 1 (baseline), day 2 and day 3 (post-testing), both before and after randomized activities.
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Perceived Mental Fatigue
Ramy czasowe: The PMFQ will be assessed on day 1 (baseline), day 2, and day 3 (post-testing).
|
The Perceived Mental Fatigue Questionnaire (PMFQ) is a novel inventory using 7-item Likert scale ( e.g., "My thinking requires effort," 1 = Not at all to 5 = Very true).
Participants are asked to reflect on their current level of mental fatigue.
The 7 items from PMFQ are summed together to create a composite fatigue value.
The total scores from each of the three days will be used to calculate an overall fatigue score, which will be used to assess group level differences across averages.
Our operational definition of overall fatigue in this outcome is the average score across each group.
|
The PMFQ will be assessed on day 1 (baseline), day 2, and day 3 (post-testing).
|
|
Energy subscale of AD ACL-SAI
Ramy czasowe: This will be assessed following randomized activities on Day 1 (baseline), Day 2, and Day 3 (post-testing).
|
The AD ACL-SAI asks respondents to select how they relate to a specific adjective in the moment by choosing between 4 answer options (1=not at all, 2=moderately so, 3=somewhat, and 4=very much so).
Each of the 5 items in the Energy subscale are summed together to create an overall Energy fatigue score.The total scores from each of the three days will be used to calculate an overall energy score, which will be used to assess group level differences across averages.
Our operational definition of overall energy in this outcome is the average score across each group.
|
This will be assessed following randomized activities on Day 1 (baseline), Day 2, and Day 3 (post-testing).
|
|
Tiredness subscale of AD ACL-SAI
Ramy czasowe: This will be assessed following randomized activities on Day 1 (baseline), Day 2, and Day 3 (post-testing).
|
The AD ACL-SAI asks respondents to select how they relate to a specific adjective in the moment by choosing between 4 answer options (1=not at all, 2=moderately so, 3=somewhat, and 4=very much so).
Each of the 5 items in the Tiredness subscale are summed together to create an overall Tiredness fatigue score.
This will be used to calculate a change score.
The total scores from each of the three days will be used to calculate an overall tiredness score, which will be used to assess group level differences across averages.
Our operational definition of overall tiredness in this outcome is the average score across each group.
|
This will be assessed following randomized activities on Day 1 (baseline), Day 2, and Day 3 (post-testing).
|
|
Attention- Assessed by Flanker Inhibitory Control and Attention task from the NIH toolbox
Ramy czasowe: This will be assessed prior to randomized activities on day 1 (baseline), and day 3 (post-testing)
|
In the Flanker task participants focus on a given stimulus while inhibiting attention to stimuli flanking it.
Participants see a row of 5 arrows and choose the button that matches the direction the middle arrow is pointing.
This test yields a standardized accuracy and processing speed change score.
|
This will be assessed prior to randomized activities on day 1 (baseline), and day 3 (post-testing)
|
|
Working Memory- Assessed by Picture Sequence task from the NIH toolbox
Ramy czasowe: This will be assessed prior to randomized activities on day 1 (baseline), and day 3 (post-testing)
|
The Picture Sequence tasks asks participants to remember a specific order of events as demonstrated by the task itself on a screen.
At the conclusion of the demonstration, the events are scrambled and the participants are instructed to place them back in the correct order.
This task yields a standardized accuracy change score.
|
This will be assessed prior to randomized activities on day 1 (baseline), and day 3 (post-testing)
|
|
Cognitive Flexibility and Attention- Assessed by Dimensional Change Card Sort Task from the NIH toolbox
Ramy czasowe: This will be assessed prior to randomized activities on day 1 (baseline), and day 3 (post-testing)
|
In the Dimensional Change Card Sort Task, participants are asked to match a series of bivalent test pictures (e.g., yellow balls and blue trucks) to the target pictures, first according to one dimension (e.g., color) and then, after a number of trials, according to the other dimension (e.g., shape).
The ensuing "switch" trials are also employed, in which the participant is required to change the dimension being matched.
For example, after 4 straight trials matching on shape, the participant may be asked to match on color on the next trial and then go back to shape, thus requiring the cognitive flexibility to quickly choose the correct stimulus.
The NIH toolbox automatically calculates an overall raw score, which takes into account both accuracy and reaction time, used to create a change score.
|
This will be assessed prior to randomized activities on day 1 (baseline), and day 3 (post-testing)
|
|
Program Evaluation - Perceived Usefulness
Ramy czasowe: This will be assessed on day 3.
|
All participants will complete an adapted version of Davis (1989) and Davis et al., (1989) perceived usefulness questionnaire (e.g., "Using the technology-delivered relaxation training program improved my thinking").
These 5 items will be measured using a 7-point Likert scale (1 = Strongly disagree, 4 = Neutral, 7 = Strongly agree) and will assess attitudes towards the technology-delivered relaxation-training program.
The 5 item's responses will be averaged and then used for a total perceived usefulness score.
|
This will be assessed on day 3.
|
|
Program Evaluation - Perceived Ease of Use
Ramy czasowe: This will be assessed on day 3.
|
All participants will complete an adapted version of Davis (1989) and Davis et al., (1989) perceived ease of use questionnaire (e.g., "I found the technology-delivered relaxation training program to be easy to use").
These 5 items will be measured using a 7-point Likert scale (1 = Strongly disagree, 4 = Neutral, 7 = Strongly agree) and will assess attitudes towards the technology-delivered relaxation-training program.
The 5 item's responses will be averaged and then used for a total perceived usefulness score.
|
This will be assessed on day 3.
|
|
Program Evaluation - Enjoyment
Ramy czasowe: This will be assessed on day 3.
|
An evaluation of participants' enjoyment of the trial will also be included.
Five questions (e.g., I enjoyed using the mindfulness training device) using a 7-point Likert scale (1 = Not at all, 4 = Neutral, 7 = Completely) will be administered.
The 5 item's responses will be averaged and then used for a total perceived usefulness score.
|
This will be assessed on day 3.
|
|
Program Evaluation - Satisfaction
Ramy czasowe: This will be assessed on day 3.
|
An evaluation of participants' satisfaction with components of the trial will also be included.
Five questions (e.g., I am satisfied with the outcomes experienced following mindfulness training) using a 7-point Likert scale (1 = Not at all, 4 = Neutral, 7 = Completely) will be administered.
The 5 item's responses will be averaged and then used for a total perceived usefulness score.
|
This will be assessed on day 3.
|
|
Program Evaluation - Open Ended
Ramy czasowe: This will be assessed on day 3.- focusing on thoughts of the program over the three appointment days, in a 1-week period.
|
An open ended evaluation of participants' experience with the trial will also be included.
This qualitative question will ask participants to expand upon their overall likes and dislikes, recommendations, and modifications will be included.
Open ended responses will be used to design and apply future interventions in this area.
|
This will be assessed on day 3.- focusing on thoughts of the program over the three appointment days, in a 1-week period.
|
Współpracownicy i badacze
Publikacje i pomocne linki
Przydatne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 16381
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Ramy czasowe udostępniania IPD
Kryteria dostępu do udostępniania IPD
Typ informacji pomocniczych dotyczących udostępniania IPD
- PROTOKÓŁ BADANIA
- SOK ROŚLINNY
- ICF
- ANALITYCZNY_KOD
- CSR
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Rak piersi
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)Jeszcze nie rekrutacjaSyndrom Lyncha | Dziedziczny zespół nowotworowy | BRCA1-Related Hereditary Breast and Ovarian Cancer Syndrome | BRCA2-Related Hereditary Breast and Ovarian Cancer SyndromeStany Zjednoczone
-
University of ChicagoJeszcze nie rekrutacjaHER2 Pozytywne nowo zdiagnozowane przerzuty przełyku, żołądka, GEJ Cancer Pacjenci ze statusem wydajności ECOG 2
-
Emory UniversityNational Cancer Institute (NCI)WycofanePrognostyczny rak piersi IV stopnia AJCC v8 | Przerzutowy nowotwór złośliwy w mózgu | Przerzutowy rak piersi | Anatomiczny IV stopień raka piersi American Joint Committee on Cancer (AJCC) v8
-
Jonsson Comprehensive Cancer CenterZakończonyRak prostaty oporny na kastrację | Przerzutowy rak prostaty | Stadium IVA raka prostaty AJCC v8 | Rak prostaty w stadium IVB AJCC v8 | Rak prostaty w stadium IV American Joint Committee on Cancer (AJCC) v8Stany Zjednoczone
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.Aktywny, nie rekrutującyNiedrobnokomórkowy rak płuc z przerzutami | Oporny na leczenie niedrobnokomórkowy rak płuc | Rak płuca w stadium IV American Joint Committee on Cancer (AJCC) v8 | Rak płuc w stadium IVA AJCC v8 | Rak płuc w stadium IVB AJCC v8Stany Zjednoczone
-
Jonsson Comprehensive Cancer CenterRekrutacyjnyRak prostaty oporny na kastrację | Przerzutowy rak prostaty | Stadium IVA raka prostaty AJCC v8 | Rak prostaty w stadium IVB AJCC v8 | Rak prostaty w stadium IV American Joint Committee on Cancer (AJCC) v8Stany Zjednoczone
-
Jonsson Comprehensive Cancer CenterZakończonyBiochemicznie nawracający rak prostaty | Przerzutowy rak prostaty | Nowotwór złośliwy z przerzutami w kości | Stadium IVA raka prostaty AJCC v8 | Rak prostaty w stadium IVB AJCC v8 | Rak prostaty w stadium IV American Joint Committee on Cancer (AJCC) v8Stany Zjednoczone
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)ZakończonyGruczolakorak gruczołu krokowego III stopnia AJCC v7 | Gruczolakorak gruczołu krokowego II stopnia AJCC v7 | Stopień I gruczolakoraka gruczołu krokowego American Joint Committee on Cancer (AJCC) v7Stany Zjednoczone
-
NRG OncologyNational Cancer Institute (NCI)ZakończonyAnatomiczny rak piersi IV stadium AJCC v8 | Prognostyczny rak piersi IV stopnia AJCC v8 | Nowotwór złośliwy z przerzutami w kości | Przerzutowy nowotwór złośliwy w węzłach chłonnych | Przerzutowy nowotwór złośliwy w wątrobie | Przerzutowy rak piersi | Przerzutowy nowotwór złośliwy w płucach | Nowotwór... i inne warunkiStany Zjednoczone, Kanada, Arabia Saudyjska, Korea Południowa
-
National Cancer Institute (NCI)ZakończonyOporny na leczenie złośliwy nowotwór lity | Nawracający złośliwy nowotwór lity | Przerzutowy złośliwy nowotwór lity | Nieoperacyjny lity nowotwór | Nawracający rak drobnokomórkowy płuca | Stopień IIIA Rak drobnokomórkowy płuca AJCC v7 | Etap IIIB Rak drobnokomórkowy płuca AJCC v7 | Rak drobnokomórkowy... i inne warunkiStany Zjednoczone
Badania kliniczne na Aerobic Exercise Only
-
Charles University, Czech RepublicUniversity Hospital Olomouc; Faculty Hospital Kralovske Vinohrady; University... i inni współpracownicyJeszcze nie rekrutacjaMigotanie przedsionków (AF)
-
Rashid Latif Medical CollegeZakończonyZespół wielotorbielowatych jajnikówPakistan
-
Universidad de La FronteraRejestracja na zaproszenieZwłóknienie płuc | Śródmiąższowa choroba płuc spowodowana chorobą ogólnoustrojową (zaburzenie) | Śródmiąższowa choroba płuc u pacjentów z reumatoidalnym zapaleniem stawówChile
-
Hôpital Léon BérardCentre Hospitalier Toulon; Groupement des Hôpitaux de l'Institut Catholique...Zakończony
-
Riphah International UniversityZakończonyFizjoterapia sportowaPakistan
-
Istanbul University - CerrahpasaRekrutacyjnyMotoryczny zespół ryzyka poznawczego | Osoby w podeszłym wieku (osoby w wieku 65 lat lub starsze) | Pacjent geriatryczny | Eksergowanie | Ćwiczenia nerwowo-mięśnioweTurcja (Türkiye)
-
Mỹ Đức HospitalZakończony
-
Istanbul UniversityIstanbul University Research FundZakończony
-
Cukurova UniversityZakończonyZespół nadpobudliwości psychoruchowej z deficytem uwagi (ADHD)Turcja (Türkiye)
-
Sanidad de Castilla y LeónZakończonySkuteczność programu poprawiającego równowagę, mobilność i zapobiegającego upadkom u osób starszych.Przypadkowe upadkiHiszpania